MarketInOut Stock Screener Log In | Sign Up

Repligen Corp

NASDAQ • Healthcare • Medical Instruments & Supplies • Quote as of 10/30/2026
Repligen Corp stock price and volume chart

Company Profile

IndustryMedical Instruments & Supplies
SectorHealthcare
ExchangeNASDAQ
Market Capitalization11,803 mln
Float59.96 mln
Earnings Date02/24/2027

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-2.74
Likely reliable

1-Year Forecast

202.22
Modest upside

Relative Strength

66 / 100
Outperforming

Debt / Equity

0.33
Low leverage

Pre-Tax Margin

1%
Break-even

Business Description

Repligen is a Massachusetts-based company founded in 1981 that makes tools and equipment used in the production of biological medicines. Its products help drug manufacturers filter, purify, monitor, and refine biological compounds throughout the manufacturing process. The company sells to pharmaceutical firms, research laboratories, and contract manufacturers across North America, Europe, Asia, and other regions worldwide.

Key Fundamentals

EPS-0.21
ROE-0.56
RPS14.28
ROIC-0.96
ROA-0.40
Interest Cover2.86
EBITDA, mln125
EV / EBITDA95.05
EV / EBIT368
Revenue, mln806
EV / Revenue14.77

Quote Details

Last 176.94
Change -11.7 (-6.2%)
Open 177.44
Volume 4,609,189
Turnover 815,549,888
Average Volume 1,453,669

Financial Ratios

Pre-Tax Profit Margin1
Leverage Ratio1.40
Current Ratio9.88
Price / Book5.16
Price / Tangible Book15.74
Price / Cash Flow80.98
Price / Free Cash Flow102
Debt / Equity0.33
Price / Sales13.41
PEG Ratio1.84

Financial Strength

Altman Z-Score9.41
Piotroski F-Score 6 / 9
Beneish M-Score-2.74
Price to Intrinsic Value4.38
Price to Graham Number17.82
1-Year Target Price202.22
Shiller PE Ratio176
Short Ratio5.48
Short % of Float11.28

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 0.01% 54 / 100   
1 Month -0.16% 59 / 100   
2 Months 35.01% 96 / 100   
6 Months 50.97% 96 / 100   
1 Year 19.17% 79 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog